Fatty Acid Amides Suppress Proliferation via Cannabinoid Receptors and Promote the Apoptosis of C6 Glioma Cells in Association with Akt Signaling Pathway Inhibition. [PDF]
Silva NMD +8 more
europepmc +1 more source
Abstract Objective To highlight key factors required to optimize multi‐mechanistic approaches with oral combination treatments for the acute management of a migraine attack. Background Given the complex multi‐factorial nature of migraine, combining treatments with different mechanisms of action should improve outcomes compared to monotherapies, but ...
Stephen Silberstein, Alan M. Rapoport
wiley +1 more source
The Sobering Sting: Oleoyl Serotonin Is a Novel Stephanoconus Snail Venom-Derived Antagonist of Cannabinoid Receptors That Counteracts Learning and Memory Deficits. [PDF]
An D +5 more
europepmc +1 more source
Adherence to Consolidated Standards of Reporting Trials (CONSORT) guidelines for reporting safety outcomes in trials of cannabinoids for chronic pain: Protocol for a systematic review [PDF]
Campbell, Fiona +6 more
core +1 more source
Microvascular Effects of Endocannabinoid Signaling in Sepsis: A Mechanistic and Systematic Review
ABSTRACT Microvascular dysfunction is a central determinant of organ failure in sepsis, reflecting early endothelial activation, increased permeability, and impaired capillary perfusion. Experimental evidence suggests that the endocannabinoid system (ECS) modulates these immunovascular processes, yet mechanistic insights remain dispersed across ...
Emanuel F. Matias +2 more
wiley +1 more source
Cornflower Extract and Its Active Components Alleviate Dexamethasone-Induced Muscle Wasting by Targeting Cannabinoid Receptors and Modulating Gut Microbiota. [PDF]
Nguyen NB +7 more
europepmc +1 more source
Beyond prediction: unveiling the prognostic power of μ-opioid and cannabinoid receptors, alongside immune mediators, in assessing the severity of SARS-CoV-2 infection. [PDF]
Tavakoli-Yaraki M +11 more
europepmc +1 more source
IUPHAR review- Preclinical models of neuropathic pain: Evaluating multifunctional properties of natural cannabinoid receptors ligands. [PDF]
Benamar K.
europepmc +1 more source
Monlunabant in adults with obesity and metabolic syndrome: Open‐label extension of a phase 2a trial
Diabetes, Obesity and Metabolism, Volume 28, Issue 5, Page 4366-4371, May 2026.
Filip K. Knop +10 more
wiley +1 more source

